(Press-News.org) Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.
The findings are published in the May 28, 2013 edition of Neuroscience Letters.
Brian Dranka, Ph.D., postdoctoral fellow at the Medical College of Wisconsin (MCW), is the first author of the paper. Balaraman Kalyanaraman, Ph.D., Harry R. & Angeline E. Quadracci Professor in Parkinson's Research, chairman and professor of biophysics, and director of the MCW Free Radical Research Center, is the corresponding author.
In a specific type of transgenic mouse called LRRK2R1441G, the animals lose coordinated movements and develop Parkinson's-type symptoms by ten months of age. In this study, the researchers treated those mice with diapocynin starting at 12 weeks. That treatment prevented the expected deficits in motor coordination.
"These early findings are encouraging, but in this model, we still do not know how this molecule exerts neuroprotective action. Further studies are necessary to discover the exact mode of action of the diaopocynin and other molecules with a similar structure," said Dr. Kalyanaraman.
Clinicians have expressed a need for earlier disease detection in Parkinson's Disease patients; the researchers believe further study of this specific mouse model may allow them to identify new biomarkers that would enable early disease detection, and ultimately allow for better patient care and quality of life.
###
Other authors of the paper include Joy Joseph, Ph.D., associate professor of biophysics; Jacek Zielonka, Ph.D., research scientist; and Allison Gifford, research technologist, all of MCW; Anumantha Kanthasamy, M.S., M.Phil, Ph.D., W.E. Lloyd Endowed Chair in Neurotoxicology and chair of the biomedical sciences department and distinguished professor; and Anamitra Ghosh, research fellow; both of the Iowa State University College of Veterinary Medicine. This research was funded by NIH grants NS039958 (to B.K.) and NS074443 (to A.K.), and by the Henry R. and Angeline E. Quadracci Chair Endowment (B.K.), and the Eugene and Linda Lloyd Chair Endowment (A.K.).
About the Medical College of Wisconsin
The Medical College of Wisconsin is the state's only private medical school and health sciences graduate school. Founded in 1893, it is dedicated to leadership and excellence in education, patient care, research and service. More than 1,200 students are enrolled in the Medical College's medical school and graduate school programs. A major national research center, it is the largest research institution in the Milwaukee metro area and second largest in Wisconsin. In FY 2010 – 11, faculty received more than $175 million in external support for research, teaching, training and related purposes, of which more than $161 million is for research. This total includes highly competitive research and training awards from the National Institutes of Health (NIH). Annually, College faculty direct or collaborate on more than 2,200 research studies, including clinical trials. Additionally, more than 1,350 physicians provide care in virtually every specialty of medicine for more than 400,000 patients annually.
Antioxidant shows promise in Parkinson's disease
2013-06-19
ELSE PRESS RELEASES FROM THIS DATE:
Staging system in ALS shows potential tracks of disease progression, Penn study finds
2013-06-19
PHILADELPHIA - The motor neuron disease Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, progresses in a stepwise, sequential pattern which can be classified into four distinct stages, report pathologists with the Perelman School of Medicine at the University of Pennsylvania in the Annals of Neurology. This post-mortem staging of ALS brain and spinal cord tissues shows, for the first time, how the fatal degenerative disease may progress from one starting point in the central nervous system to other regions of brain and spinal cord. As evidence mounts ...
The rhythm of the Arctic summer
2013-06-19
This news release is available in German. Our internal circadian clock regulates daily life processes and is synchronized by external cues, the so-called Zeitgebers. The main cue is the light-dark cycle, whose strength is largely reduced in extreme habitats such as in the Arctic during the polar summer. Using a radiotelemetry system a team of researchers from the Max Planck Institute for Ornithology have now found, in four bird species in Alaska, different daily activity patterns ranging from strictly rhythmic to completely arrhythmic. These differences are attributed ...
U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone'
2013-06-19
ANN ARBOR—Spring floods across the Midwest are expected to contribute to a very large and potentially record-setting 2013 Gulf of Mexico "dead zone," according to a University of Michigan ecologist and colleagues who released their annual forecast today, along with one for the Chesapeake Bay.
The Gulf forecast, one of two announced by the National Oceanic and Atmospheric Administration, calls for an oxygen-depleted, or hypoxic, region of between 7,286 and 8,561 square miles, which would place it among the 10 largest on record.
The low end of the forecast range is well ...
British women 50 percent less likley to recieve treatment for common menopausal symptoms
2013-06-19
Crawley, UK-- New data, published today in Menopause International, suggests that post-menopausal women in Britain are experiencing less sex, and less satisfying sex compared to their European and North American counterparts1, because they are considerably less likely to access appropriate treatment for a common, taboo condition called vaginal atrophy1.
The first-of-its-kind study, called the CLarifying vaginal atrophy's impact On SEx and Relationships (CLOSER) study, showed that British post-menopausal women with vaginal atrophy are more likely to experience less sex1, ...
No danger of cancer through gene therapy virus
2013-06-19
In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed AAV-LPL S447X for the treatment of a rare inherited metabolic disease called lipoprotein lipase deficiency (LPLD) which affects approximately one or two out of one million people. The disease causes severe, life-threatening inflammations of the pancreas. Afflicted individuals carry a defect in the gene coding for the lipoprotein lipase enzyme which ...
Outlook is grim for mammals and birds as human population grows
2013-06-19
COLUMBUS, Ohio – The ongoing global growth in the human population will inevitably crowd out mammals and birds and has the potential to threaten hundreds of species with extinction within 40 years, new research shows.
Scientists at The Ohio State University have determined that the average growing nation should expect at least 3.3 percent more threatened species in the next decade and an increase of 10.8 percent species threatened with extinction by 2050.
The United States ranks sixth in the world in the number of new species expected to be threatened by 2050, the research ...
University of Tennessee professor finds prehistoric rock art connected; maps cosmological belief
2013-06-19
It is likely some of the most widespread and oldest art in the United States. Pieces of rock art dot the Appalachian Mountains, and research by University of Tennessee, Knoxville, anthropology professor Jan Simek finds each engraving or drawing is strategically placed to reveal a cosmological puzzle.
Recently, the discoveries of prehistoric rock art have become more common. With these discoveries comes a single giant one—all these drawing and engravings map the prehistoric peoples' cosmological world.
The research led by Simek, president emeritus of the UT system and ...
New data on islet autoantibodies in young children defines early type 1 diabetes development
2013-06-19
New York, NY, June 19, 2013 – A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum München, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes (T1D), highlighting the importance of pre-diabetes research into possible preventions for the disease. The study, "Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children," was published today in The Journal of the American Medical Association.
Researchers in Colorado (DAISY study), ...
Breakthrough research of essential molecule reveals important targets in diabetes and obesity
2013-06-19
DETROIT – Insulin is the most potent physiological anabolic agent for tissue-building and energy storage, promoting the storage and synthesis of lipids, protein and carbohydrates, and inhibiting their breakdown and release into the circulatory system. It also plays a major role in stimulating glucose entry into muscle tissue, where the glucose is metabolized and removed from the blood following meals. But gaps exist in understanding the precise molecular mechanisms by which insulin regulates glucose uptake in fat and muscle cells.
A research team led by Assia Shisheva, ...
Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers
2013-06-19
Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms (SNPs). The goal is to better predict a prostate cancer's aggressiveness to avoid unnecessary radical treatment.
Their study was published in the online journal PLOS ONE in April.
According to the authors, prostate cancer accounts for 20 percent of all cancers and 9 percent of cancer deaths. It is ...